We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
-0.72%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$16.7B
AUM Growth
-$332M
Cap. Flow
-$57.8M
Cap. Flow %
-0.35%
Top 10 Hldgs %
17.41%
Holding
2,287
New
114
Increased
795
Reduced
1,162
Closed
171
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GENI icon
776
Genius Sports
GENI
$2.11B
$3.75M 0.02%
+200,935
New +$3.68M
RIO icon
777
Rio Tinto
RIO
$164B
$3.74M 0.02%
55,983
-3,857
-6% -$301K
TENB icon
778
Tenable Holdings
TENB
$4.01B
$3.74M 0.02%
81,032
+23,245
+40% +$1.02M
GDV icon
779
Gabelli Dividend & Income Trust
GDV
$2.66B
$3.73M 0.02%
144,519
+17,225
+14% +$456K
HAPN
780
Happen Inc
HAPN
$2.24B
$3.73M 0.02%
+131,931
New +$3.27M
TTWO icon
781
Take-Two Interactive
TTWO
$46.1B
$3.72M 0.02%
24,172
-3,939
-14% -$638K
AOD
782
abrdn Total Dynamic Dividend Fund
AOD
$1.12B
$3.72M 0.02%
382,071
-25,967
-6% -$266K
ODFL icon
783
Old Dominion Freight Line
ODFL
$44.9B
$3.71M 0.02%
25,924
-20,738
-44% -$2.88M
IQV icon
784
IQVIA
IQV
$39.3B
$3.71M 0.02%
15,469
-20,679
-57% -$5.22M
RUN icon
785
Sunrun
RUN
$2.46B
$3.7M 0.02%
84,151
+59,393
+240% +$2.83M
MRTX
786
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$3.7M 0.02%
20,895
-693
-3% -$111K
JHI
787
John Hancock Investors Trust
JHI
$117M
$3.69M 0.02%
197,844
+13,625
+7% +$257K
DOX icon
788
Amdocs
DOX
$6.22B
$3.69M 0.02%
48,724
+2,522
+5% +$195K
EFA icon
789
iShares MSCI EAFE ETF
EFA
$80.2B
$3.67M 0.02%
47,008
+3,538
+8% +$283K
KAHC.WS
790
DELISTED
KKR Acquisition Holdings I Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
KAHC.WS
$3.67M 0.02%
3,818,638
-1,053
-0% -$1.18K
TDS icon
791
Telephone and Data Systems
TDS
$3.75B
$3.66M 0.02%
187,775
-72,474
-28% -$1.5M
DVA icon
792
DaVita
DVA
$11.7B
$3.66M 0.02%
31,481
-3,009
-9% -$377K
IGD
793
Voya Global Equity Dividend and Premium Opportunity Fund
IGD
$517M
$3.65M 0.02%
617,926
+116,615
+23% +$706K
CNC icon
794
Centene
CNC
$32.5B
$3.64M 0.02%
58,441
-35,530
-38% -$2.37M
ECL icon
795
Ecolab
ECL
$79.9B
$3.63M 0.02%
17,392
-2,928
-14% -$642K
MQT
796
DELISTED
BlackRock MuniYield Quality Fund II
MQT
$3.61M 0.02%
250,869
+97,414
+63% +$1.44M
AZPN
797
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$3.58M 0.02%
29,161
+3,782
+15% +$464K
AAP icon
798
Advance Auto Parts
AAP
$3.49B
$3.58M 0.02%
17,125
-1,179
-6% -$246K
COR
799
DELISTED
Coresite Realty Corporation
COR
$3.57M 0.02%
25,785
-3,821
-13% -$546K
HUBB icon
800
Hubbell
HUBB
$27.2B
$3.54M 0.02%
19,584
+4,846
+33% +$945K

Similar funds

Guggenheim Capital's Q3 2021 Portfolio in Review

As of Q3 2021, Guggenheim Capital held 2,287 positions worth $16.7B, down 2% from $17B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Guggenheim Capital's Q3 2021 filing shows 114 new, 795 increased, 1,162 reduced and 171 closed positions. Its largest new stake was Logistics Innovation Technologies Corp. Class A Common Stock: 4,000,000 shares worth $38.6M. The largest sale was Alexion Pharmaceuticals, an estimated $41.8M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Guggenheim Capital's largest Q3 2021 buy was Logistics Innovation Technologies Corp. Class A Common Stock: 4,000,000 shares worth $38.6M.
  • Guggenheim Capital added most to iShares Core US Aggregate Bond ETF in Q3 2021, an estimated $50M increase.
  • Guggenheim Capital's biggest Q3 2021 reduction was Matterport, Inc. Class A Common Stock, cutting an estimated $32.4M.
  • Guggenheim Capital fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $41.8M.
  • Guggenheim Capital's ten largest holdings make up 17% of its $16.7B portfolio in Q3 2021.
  • Guggenheim Capital opened 114 new positions and closed 171 in Q3 2021.
  • Guggenheim Capital's portfolio value fell 2% quarter-over-quarter to $16.7B.

Based on Guggenheim Capital's 13F filing for Q3 2021, filed 15 Nov 2021.